RWB
LJPC

RMR Wealth Builders’s La Jolla Pharmaceutical Company LJPC Stock Holding History

RMR Wealth Builders’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,000
Closed -$34K – 796
2021
Q1 		$34K Sell
8,000
-1,400
-15% -$7.71K 0.01% 432
2020
Q4 		$36K Sell
9,400
-12,031
-56% -$51.4K 0.02% 294
2020
Q3 		$86K Buy
21,431
+11,331
+112% +$46.9K 0.02% 210
2020
Q2 		$43K Buy
+10,100
New +$61.5K 0.04% 241
2019
Q4 		$31K Buy
+7,800
New +$46.1K 0.03% 274

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RMR Wealth Builders's LJPC Position: Q2 2021 in Review

RMR Wealth Builders sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 8,000 shares — an estimated $34K sold.

RMR Wealth Builders first reported a position in LJPC in Q4 2019 and held it in 5 quarters. The position peaked at $86K in Q3 2020. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • RMR Wealth Builders reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 8,000 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $34K.
  • RMR Wealth Builders first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 5 quarters.
  • RMR Wealth Builders's La Jolla Pharmaceutical Company position peaked at $86K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.